The rise of copyright’s blockbuster initially sparked a boom for major pharmaceutical companies, however recent shifts present a uncertain picture for shareholders. Lower-cost competitors are eroding revenue, and https://amberfvee715937.win-blog.com/22441386/sildenafil-and-big-pharma-a-precarious-investment